NYSE: PTN - Palatin Technologies, Inc.

छह महीने के लिए लाभप्रदता: -79.47%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Palatin Technologies, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Palatin Technologies, Inc.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases.

अधिक जानकारी
In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a peptide mimetic molecule with amino acid mimetic structure and amino acids properties; and L8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 1993-10-28
ISIN US6960775020
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://palatin.com
Цена ао 0.7218
प्रति दिन मूल्य परिवर्तन: 0% (0.2053)
प्रति सप्ताह मूल्य परिवर्तन: -53.55% (0.442)
प्रति माह मूल्य परिवर्तन: -74.66% (0.8101)
3 महीने में कीमत में बदलाव: -80.99% (1.08)
छह महीने में कीमत में बदलाव: -79.47% (1)
प्रति वर्ष मूल्य परिवर्तन: -89.19% (1.9)
3 वर्षों में मूल्य परिवर्तन: -54.38% (0.45)
5 वर्षों में मूल्य परिवर्तन: -48.68% (0.4)
वर्ष की शुरुआत से मूल्य परिवर्तन: -81.5% (1.11)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 5.96 2
P/BV -239.91 0
P/E 0 0
EV/EBITDA -0.6135 0
कुल: 4

क्षमता

नाम अर्थ श्रेणी
ROA, % -207.35 0
ROE, % -263431.19 0
कुल: 1.67

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0.0071

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.0203 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 3705.16 10
लाभप्रदता Ebitda, % 23.01 4
लाभप्रदता EPS, % -10.08 0
कुल: 4
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Armistice Capital, LLC 590000 3.66
Vanguard Group Inc 548622 3.4
LPL Financial LLC 146396 0.91
Blackrock Inc. 119518 0.74
Geode Capital Management, LLC 94148 0.58
State Street Corporation 30295 0.19
Susquehanna International Group, LLP 30062 0.19
Bridgeway Capital Management, Inc. 26124 0.16
Northern Trust Corporation 25097 0.16
Montis Financial, LLC 20964 0.13



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Dr. Carl Spana Ph.D. Co-Founder, President, CEO & Director 979k 1962 (63 वर्ष)
Mr. Stephen T. Wills CPA, MST CFO, COO, Executive VP, Treasurer & Secretary 910.55k 1957 (68 साल)
Burns McClellan Vice President of Investor Relations N/A
Mr. Stephen A. Slusher Esq. Chief Legal Officer N/A
Dr. Michael B. Raizman M.D. Chief Medical Officer N/A
Mr. James E. Hattersley Senior Vice President of Business Development N/A 1960 (65 साल)
Mr. John Dodd Ph.D. Senior Vice President of Preclinical Development N/A
Mr. Robert Jordan Senior Vice President of Program Operations N/A

पता: United States, Cranbury. NJ, Cedar Brook Corporate Center - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://palatin.com